Treating prehypertension: Medically sound and economically viable

Blood Pressure

Volumn 18, Issue 6, 2009, Pages 300-303

  Kiely, Amanda Elisabeth ^a   Kwatra, Shawn Gaurav ^b   Kwatra, Madan Mohan ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cognition and prehypertension; Complications of prehypertension; Diabetes; Incidence of prehypertension; Pharmacotherapy; Prehypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE DEFECT; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DRUG COST; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREHYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION;

EID: 73649099512     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037050903444024     Document Type: Review

References (27)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al.. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289:2560-2572.
2. Mancia G, De Backer G, Dominiczak A, Dominiczak A, Cifkova R, Fagard R, et al.. Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea; Sociedad Europea de Cardiología. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol. 2007;60:968.e1-94
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
4. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al.. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146.
5. Agyemang C, van Valkengoed I, van den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch in Amsterdam, the Netherlands: the SUNSET study. Eur J Cardiovasc Prev Rehabil. 2007;14:775-781.
6. Godwin M, Pike A, Kirby A, Jewer C, Murphy L. Prehypertension and hypertension in a primary care practice. Can Fam Physician. 2008;54:1418-1423.
7. Sun Z, Zheng L, Xu C, Li J, Zhang X, Liu S, et al.. Prevalence of prehypertension, hypertension and associated risk factors in Mongolian and Han Chinese populations in Northeast China. Int J Cardiol. 2008;128:250-254.
8. Pednekar MS, Gupta R, Gupta PC. Association of blood pressure and cardiovascular mortality in India: Mumbai cohort study. Am J Hypertens. 2009;22:1076-1084.
9. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371: 1513-1518.
10. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al.. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
11. Hansen TW, Staessen JA, Zhang H, Torp-Pedersen C, Rasmussen S, Thijs L, et al.. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens. 2007;20:483-491.
12. Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005;3:294-299.
13. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, et al.. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007; 115:855-860.
14. Freitag MH, Peila R, Masaki K, Petrovitch H, Ross GW, White LR, et al.. Midlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study. Stroke. 2006; 37:33-37.
15. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al.. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63:686-692.
16. Knecht S, Wersching H, Lohmann H, Bruchmann M, Duning T, Dziewas R, et al.. High-normal blood pressure is associated with poor cognitive performance. Hypertension. 2008;51:663-668.
17. Mullican DR, Lorenzo C, Haffner SM. Is prehypertension a risk factor for the development of type 2 diabetes? Diabetes Care. 2009;32:1870-1872.
18. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, et al.. Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study. J Am Soc Nephrol. 2007;18:2135-2142.
19. Mitka M. Drug therapy for prehypertension questioned. JAMA. 2006;296:2787-2788.
20. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al.. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354:1685-1697.
21. Chobanian AV. Prehypertension revisited. Hypertension. 2006;48:812-814.
22. Svetkey LP. Management of prehypertension. Hypertension. 2005;45:1056-1061.
23. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al.. Effects of comprehensive lifestyle modifi cation on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006;144:485-495.
24. Moser M. Results of ALLHAT: is this the fi nal answer regarding initial antihypertensive drug therapy? Arch Intern Med. 2003;163:1269-1273.
25. Freis ED. The effi cacy and safety of diuretics in treating hypertension. Ann Intern Med. 1995;122:223-226.
26. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4:e283.
27. Pitt B. Prehypertension. To treat, or not to treat: that is the question. Am J Hypertens. 2007;20:492.